癌におけるNR2F2の役割 (レビュー)
PubMedで要約を見る
まとめ
この要約は機械生成です。核受容体サブファミリー2,グループF,メンバー2 (NR2F2) は,腫瘍抑制剤と腫瘍抑制剤の両方として作用する. NR2F2を理解する
科学分野
- 分子生物学
- 癌 研究
- 遺伝学
背景
- 腫瘍の発生率と死亡率は 毎年上昇しています
- 1986年に発見された核受容体サブファミリー2,グループF,メンバー2 (NR2F2) は,遺伝子転写を調節する.
- 腫瘍の進行におけるNR2F2の正確な役割は,まだ完全に理解されていません.
研究 の 目的
- マルチオミックスのアプローチを用いて,様々な癌の種類におけるNR2F2の多面的な役割を解明する.
- 腫瘍増殖,アポトーシス,および上皮-メゼンキマ移行に対するNR2F2の影響を調査する.
- NR2F2が新たながん治療の標的となる可能性を評価する.
主な方法
- 癌におけるNR2F2機能に関する既存の文献のレビュー
- NR2F2の文脈に依存する役割を理解するために,マルチオミックスのデータを分析する.
- 主要な癌の特徴に対するNR2F2の影響の検討
主要な成果
- NR2F2は,異なる悪性腫瘍における腫瘍誘発因子または腫瘍抑制剤として作用し,文脈に依存する機能を発揮する.
- NR2F2は,腫瘍増殖,アポトーシス,および上皮- 中間酵素の移行を有意に調節する.
- マルチオミックスのデータは,がんの進行に対するNR2F2の影響を裏付ける複雑なメカニズムについての洞察を提供します.
結論
- NR2F2は,様々な腫瘍の進行における重要な決定因子です.
- NR2F2のメカニズムの理解は,標的がん治療における臨床的有用性を明らかにすることができます.
- NR2F2は,がんと闘うための新しい治療戦略を開発するための潜在的なターゲットです.
関連する概念動画
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

